Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients

Kidney Medicine(2020)10.1016/j.xkme.2020.01.010Source: DataRank Database

SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients is a research paper published in Kidney Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (16)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Cary R. Boyd‐Shiwarski ORCID,Pengfei Liu ORCID,Danica Novacic ORCID,David Cassiman ORCID,Evan C. Ray ORCID

Live enrichment

PubMed:32734255 PMC:PMC7380441

NIDDK NIH HHS

Grant: K08 DK118211

NIDDK NIH HHS

Grant: K08 DK110332

National Institutes of Health

Grant: 3K08DK110332-05S1

Proteolytic activation of ENaC in Proteinuric Kidney Disease

National Institutes of Health

goldLicense: CC BY NC ND

Unpaywallhttps://doi.org/10.1016/j.xkme.2020.01.010

Europe_PMChttps://europepmc.org/articles/PMC7380441

Europe_PMChttps://europepmc.org/articles/PMC7380441?pdf=render

https://pubmed.ncbi.nlm.nih.gov/32734255

http://dx.doi.org/10.1016/j.xkme.2020.01.010

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

MagnesiumDiabetesType 2 diabetesDapagliflozinHypomagnesemiaSglt2 InhibitorsCanagliflozinEmpagliflozinEXCRETIONScience & Technology3202 Clinical sciencesCase ReportUrology & NephrologyLife Sciences & Biomedicine

Sustainable Development Goals

SDG 3: 3. Good health

SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients

FAIR Checklist

Authors (5)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)